Work

Phase I trial of oral CP-547,632 (VEGFR2) in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3014

Authors: R. B. Cohen, G. Simon, C. J. Langer, J. R. Schol, J. McHale, P. Eisenberg, J. D. Hainsworth, K. F. Liau, D. Healey

Institutions: Fox Chase Cancer Center, Pfizer (United States), Moffitt Cancer Center, Sarah Cannon

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2411632379

Cites:

Cited by: 14

Related to: 10